PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Aug-2025 Cambridge Cognition launches Speaker Identification Solution to Safeguard Clinical Trial Integrity Cambridge Cognition
12-Aug-2025 Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron
12-Aug-2025 MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin ACCESS Newswire
12-Aug-2025 Lilly and UK Government announce obesity pathway innovation programme for up to £85 million Lilly
12-Aug-2025 Understanding The Growth Of The Clear Aligners Market By 2035 MBI
12-Aug-2025 Vheda Health Ranks No. 662 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies ACCESS Newswire
12-Aug-2025 Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept Mabylon AG
12-Aug-2025 Global Fitness Equipment Market Valuation and Growth Forecast to 2035 MBI
12-Aug-2025 Microbiome Therapeutics Market Size, Growth, Trends & Forecast (2025–2035) VMR
12-Aug-2025 Adeno-Associated Virus (AAV) Gene Therapy Market Vantage Market Research
12-Aug-2025 Cystic Fibrosis Market Trends, Forecast, and Insights (2025–2035) VMR
12-Aug-2025 Nutraceuticals CDMO Market – In-depth Analysis & Future Outlook Vantage Market Research
12-Aug-2025 Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine ACCESS Newswire
12-Aug-2025 Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board Gerresheimer AG
12-Aug-2025 Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd. ACCESS Newswire
12-Aug-2025 Global Multiple Myeloma Market Poised for Significant Growth, Driven by Advances in Treatment and Rising Prevalence Market Reports
12-Aug-2025 Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 Dermapharm Holding SE
12-Aug-2025 Infectious Disease Diagnostics Market: A Deep Dive into Growth and Innovation Market Reports
12-Aug-2025 Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals S.p.A.
12-Aug-2025 SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma AG & Co. KGaA